15-Year-Old Kenyan Girl With Rare Autoimmune Disease Successfully Treated With Cell-based Therapy-Maharashtra Government Inks MoU with IBM Technology for AI Centers-Governor C. P. Radhakrishnan visits Prime Minister Narendra Modi-AMRIT MAHOTSAV OF SHREE MARKET SILK MERCHANTS ASSOCIATION ENDED ON 14TH APRIL, 2025 WITH ALL ITS GRANDEUR-Agra Startup Jatbat Playmax Media Aims to Entertain and Educate with Diverse Book Selection-Indkal Technologies Cements It's Mumbai Presence through Strategic Partnership with Digi1 Electronics-Shree Market Silk Merchants Association (SMSMA) to Celebrate Completion of Amrut Mahotsav on 14th April-SUPREME COURT TAKES COGNIZANCE OF CHILD SAFETY CONCERNS IN DIGITAL SPACE-TechnoServe and The Solvent Extractors’ Association of India Sign Landmark MoU to Advance Edible Oil Fortification-'Economic Nationalism' to Strengthen Domestic Supply Chains at FICCI’s 98th Foundation Day-Piyush Goyal

#Dr. Ruchi Sogarwal Head-Public Affairs & Patient Advocacy Takeda India

BUSINESS, Corporate, CSR, Finance, HOME, Hospital, Health & Pharma, INDUSTRY, INTERNATIONAL, Investment, NATION, PHOTO NEWS, Research & Analysis, STATE May 9, 2022

Takeda and United Nations Global Compact Network of India (UNGCNI) Strengthening the Access to Rare Disease Treatment in India Join Hands

MUMBAI, 9 MAY, 2022 (GPN): In November 2021, Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, together with UNGCNI launched a national initiative for improving early access to treatment for Rare Disease Patients in India….